Anaplastic thyroid cancer: Multimodal treatment results

ecancermedicalscience

Volumn 8, Issue 1, 2014, Pages

  Taissoun Aslan, Zaki Antonio ^a   Granados García, Martín ^a   Luna Ortiz, Kuauhyama ^a   Guerrero Huerta, Francisco Javier ^a   Gómez Pedraza, Antonio ^a   Ñamendys Silva, Silvio A ^a   Meneses García, Abelardo ^a   Ordoñez Mosquera, Juliana María ^b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSIDAD MILITAR NUEVA GRANADA   (Colombia)

Author keywords

Anaplastic thyroid cancer; Multimodal treatment; Prognoses; Thyroid cancer

Indexed keywords

EID: 84906057293     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2014.449     Document Type: Article

References (41)

1. Neff RL et al (2008) Anaplastic thyroid cancer Endocrinol Metab Clin North Am 37(2) 525-38 DOI: 10.1016/j.ecl.2008.02.003 PMID: 18502341 (Pubitemid 351711678)
2. Hundahl SA et al (1998) A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the US: 1985-1995 Cancer 83(12) 2638-48 (Pubitemid 29019586)
3. Akslen LA et al (1990) Incidence of thyroid cancer in Norway 1970-1985. Population review on time trend, sex, age, histological type and tumor stage in 2625 cases APMIS 98 549-58 DOI: 10.1111/j.1699-0463.1990.tb01070.x PMID: 2383397 (Pubitemid 20239175)
4. Davies L and Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002 JAMA 295(18) 2164-67 DOI: 10.1001/jama.295.18.2164 PMID: 16684987
5. Kitamura Y et al (1999) Immediate causes of death in thyroid carcinoma: clinic pathological analysis of 161 fatal cases J Clin Endocrinol Metab 84 4043-49 DOI: 10.1210/jcem.84.11.6115 PMID: 10566647 (Pubitemid 30644192)
6. Kebebew E et al (2005) Anaplastic thyroid carcinoma treatment outcome and prognostic factors Cancer 103(7)1330-35 DOI: 10.1002/cncr.20936 PMID: 15739211 (Pubitemid 40410726)
7. Are C and Shaha AR (2006) Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches Ann Surg Oncol 13(4) 453-64 DOI: 10.1245/ASO.2006.05.042 PMID: 16474910
8. Kim TY et al (2007) Prognostic factors for Korean patients with anaplastic thyroid carcinoma Head Neck 29(8) 765-72 DOI: 10.1002/hed.20578 PMID: 17274052
9. Tennvall J et al (2002) Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery Br J Cancer 86(12) 1848-853 DOI: 10.1038/sj.bjc.6600361 PMID: 12085174 PMCID: 2375444
10. Giuffrida D and Gharib H (2000) Anaplastic thyroid carcinoma: current diagnosis and treatment Ann Oncol 11(9) 1083-89 DOI: 10.1023/A:1008322002520 PMID: 11061600
11. Edge SB et al (2010) AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual 7th ed. Springer-Verlag, New York
12. Smallridge RC and Copland JA (2010) Anaplastic thyroid carcinoma: pathogenesis and emerging therapies Clin Oncol (R Coll Radiol) 22 486-97 DOI: 10.1016/j.clon.2010.03.013
13. Akaishi J et al (2011) Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma Thyroid 21(11) 1183-89 DOI: 10.1089/thy.2010.0332 PMID: 21936674
14. Nagaiah G et al (2011) Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment J Oncol DOI: 10.1155/2011/542358 PMID: 21772843 PMCID: 3136148
15. Jiang JY and Tseng FY (2006) Prognostic factors of anaplastic thyroid carcinoma J Endocrinol Invest 29(1) 11-17 DOI: 10.1007/ BF03349171 PMID: 16553028
16. Haigh PI et al (2001) Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival Cancer 91(12) 2335-342 PMID: 11413523 (Pubitemid 32552820)
17. Chang HS et al (2005) Anaplastic thyroid carcinoma: a therapeutic dilemma Yonsei Med J 46(6) 759-64 DOI: 10.3349/ ymj.2005.46.6.759 PMID: 16385650 PMCID: 2810588
18. Tan RK et al (1995) Anaplastic carcinoma of the thyroid: a 24-year experience Head Neck 17(1) 41-47 DOI: 10.1002/hed.2880170109 PMID: 7883548
19. Aldinger KA et al (1978) Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid Cancer 41(6) 41 2267-75
20. Venkatesh YS et al (1990) Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases Cancer Suppl 66(2):321-30 (Pubitemid 20205915)
21. Us-Krasovec M et al (1996) Anaplastic thyroid carcinoma in fine needle aspirates Acta Cytol Suppl 40(5) 953-58 DOI: 10.1159/000334007 (Pubitemid 26322348)
22. Tacha D, Zhou D and Cheng L (2011) Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study Appl Immunohistochem Mol Morphol Suppl 19(4) 293-299 DOI: 10.1097/PAI. 0b013e3182025f66
23. LiVolsi VA, Brooks JJ and Arendash-Durand B (1987) Anaplastic thyroid tumors Immunohistology Am J Clin Pathol Suppl 87(4) 434-42
24. Takashima S et al (1990) CT evaluation of anaplastic thyroid carcinoma Am J Roentgenol Suppl 11(2) 631-67
25. Chen J et al (2008) Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002 Am J Clin Oncol Suppl 31(5) 460-64 DOI: 10.1097/ COC.0b013e31816a61f3
26. Junor EJ, Paul J and Reed NS (1992) Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy Eur J Surg Oncol Suppl 18(4) 83-88
27. McIver B et al (2001) Anaplastic thyroid carcinoma: a 50-year experience at a single institution Surgery Suppl 130(6) 1028-34 DOI: 10.1067/msy.2001. 118266 (Pubitemid 34014569)
28. Wang Y et al (2006) Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens Cancer Suppl 107(8) 1786-792 DOI: 10.1002/cncr.22203 (Pubitemid 44582947)
29. Shimaoka K et al (1985) A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma Cancer Suppl 56(9) 2155-160 (Pubitemid 16236586)
30. Mitchel FW et al (2002) Hyperfractionated radiation therapy and adriamycin for anaplastic thyroid cancer Proc Am Soc Clin Oncol 21 [abstract] 931
31. Tennvall J et al (1990) Anaplasticthyroid carcinoma Doxorubicin, hyperfractionated radiotherapy and surgery Acta Oncol Suppl 29(8) 1025-28 DOI: 10.3109/02841869009091794
32. Koussis H et al (2006) Multimodality therapeutic approach in anaplastic thyroid cancer (ATC): study of 56 patients J Clin Oncol 24 18S, suppl, ASCO Annual Meeting Proceedings Part I
33. Wallin G et al (2004) Anaplastic giant cell thyroid carcinoma Scand J Surg 93(4) 272-77 (Pubitemid 40095953)
34. De Crevoisier R et al (2004) Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy Int J Radiat Oncol Biol Phys 60(4) 1137-143 DOI: 10.1016/j.ijrobp.2004.05.032 (Pubitemid 39440799)
35. Swaak-Kragten AT et al (2009) Multimodality treatment for anaplastic thyroid carcinoma-treatment outcome in 75 patients Radiother Oncol 92(1) 100-4 DOI: 10.1016/j.radonc.2009.02.016 PMID: 19328572
36. Sherman EJ et al (2011) Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review Radiother Oncol Suppl 101(3) 425-30 DOI: 10.1016/j.radonc.2011.09.004
37. Foote RL et al (2011) Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy Thyroid 21(1) 25-30 DOI: 10.1089/thy.2010.0220
38. Ito K et al (2012) Multimodality therapeutic outcomes in anaplastic thyroid carcinoma: improved survival in subgroups of patients with localized primary tumors Head Neck 34(2) 230-37 DOI: 10.1002/hed.21721
39. Abdel-Rahman O and Fouad M (2014) Risk of thyroid dysfunction in patients with solid tumors treated with VEGF receptor tyrosine kinase inhibitors: a critical literature review and meta analysis Expert Rev Anticancer Ther 13 1-11 DOI: 10.1586/14737140.2014.929501
40. Kloos R et al (2009) Phase II Trial of Sorafenib in Metastatic Thyroid Carcinoma J Clin Oncol 27(10) 1675-684 DOI: 10.1200/ JCO.2008.18.2717 PMID: 19255327 PMCID: 2668972
41. Savvides P et al (2013) Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid Thyroid 23(5) 600-04 DOI: 10.1089/thy.2012.0103 PMCID: 3643255